학술논문

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.
Document Type
Article
Source
Investigational New Drugs; Jun2022, Vol. 40 Issue 3, p622-633, 12p
Subject
COMBINATION drug therapy
PROTEIN kinase inhibitors
HEAD & neck cancer
CHEMORADIOTHERAPY
TREATMENT effectiveness
RANDOMIZED controlled trials
ACETIC acid
PLATELET count
DRUGS
CISPLATIN
PATIENT compliance
SQUAMOUS cell carcinoma
PATIENT safety
Language
ISSN
01676997
Abstract
Copyright of Investigational New Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)